Microbiome Derived Metabolites in CKD and ESRD

Rohan Paul, Carolyn Feibig, Dominic S. Raj

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

The gut microbiome encompasses the complex and vast landscape of microbes that normally colonize the gastrointestinal tract. Its quintessentially symbiotic presence is reflected in its role in various physiological processes vital to human health. A converse entity—gut dysbiosis refers to a disrupted microbial state in which adverse metabolites, endotoxins, and other pro-inflammatory mediators are known to accumulate. Downstream consequences include inflammation, immune dysregulation, cardiovascular disease, obesity, insulin resistance, and progression of underlying chronic kidney disease. Current insights into the origins and mechanisms of such pathogenic mediators and metabolites are reviewed here.

Original languageEnglish
Title of host publicationTechnological Advances in Care of Patients with Kidney Diseases
PublisherSpringer Singapore
Pages45-60
Number of pages16
ISBN (Electronic)9783031119422
ISBN (Print)9783031119415
DOIs
StatePublished - Jan 1 2022

Keywords

  • Cardiovascular disease
  • Chronic kidney disease
  • Dysbiosis
  • Microbiome
  • Prebiotics
  • Probiotics
  • Synbiotics

Fingerprint

Dive into the research topics of 'Microbiome Derived Metabolites in CKD and ESRD'. Together they form a unique fingerprint.

Cite this